Q1 2026 Holdings
Filed 2026-05-15 | 35 holdings | $16.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $1.4M | 4,450 | 8.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.3M | 67,500 | 7.5% |
| Royalty Pharma PLC(RPRX) | SHS CLASS A | G7709Q104 | $1.0M | 21,400 | 6.1% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $975.8K | 820,000 | 5.8% |
| Geron Corp(GERN) | COM | 374163103 | $861.2K | 578,000 | 5.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $841.0K | 36,000 | 5.0% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $770.6K | 128,650 | 4.6% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $691.5K | 112,434 | 4.1% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $660.3K | 62,000 | 3.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $620.2K | 28,500 | 3.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $517.9K | 8,100 | 3.1% |
| CUE Biopharma Inc(CUE) | COM | 22978P106 | $506.4K | 2,202,854 | 3.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $442.4K | 80,000 | 2.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $437.4K | 51,700 | 2.6% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $417.2K | 5,500 | 2.5% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $407.4K | 465,000 | 2.4% |
| Humacyte Inc(HUMA) | COM | 44486Q103 | $394.4K | 650,000 | 2.4% |
| Viatris Inc(VTRS) | COM | 92556V106 | $374.2K | 27,700 | 2.2% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $374.0K | 46,000 | 2.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $371.3K | 5,000 | 2.2% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $326.3K | 18,000 | 2.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $307.9K | 86,000 | 1.8% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $305.1K | 13,500 | 1.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $286.7K | 9,100 | 1.7% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $284.4K | 10,500 | 1.7% |
| Seres Therapeutics Inc(MCRB) | COM NEW | 81750R201 | $280.0K | 31,570 | 1.7% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $264.1K | 19,000 | 1.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $240.3K | 14,700 | 1.4% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $222.9K | 26,600 | 1.3% |
| Azenta Inc(AZTA) | COM | 114340102 | $205.0K | 9,700 | 1.2% |
| Innoviva Inc(INVA) | COM | 45781M101 | $191.1K | 8,200 | 1.1% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $143.4K | 10,200 | 0.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $123.7K | 5,250 | 0.7% |
| Innate Pharma S A(IPHA) | SPONSORED ADS | 45781K204 | $103.9K | 81,151 | 0.6% |
| Spruce Biosciences Inc(SPRB) | COM NEW | 85209E208 | $65.4K | 1,000 | 0.4% |